Brokerages Set Option Care Health, Inc. (NASDAQ:OPCH) PT at $31.25

Option Care Health, Inc. (NASDAQ:OPCH) has earned a consensus rating of “Moderate Buy” from the fourteen research firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $30.5385.

A number of equities research analysts have recently commented on the stock. Stephens set a $30.00 price target on shares of Option Care Health in a report on Friday, May 1st. Truist Financial set a $30.00 price target on shares of Option Care Health in a report on Friday, May 1st. Weiss Ratings downgraded shares of Option Care Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. JPMorgan Chase & Co. lowered their price target on shares of Option Care Health from $40.00 to $33.00 and set an “overweight” rating for the company in a report on Monday, May 4th. Finally, Bank of America downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and set a $22.00 price target for the company. in a report on Friday, May 1st.

Insider Activity at Option Care Health

In related news, CEO John Charles Rademacher bought 12,500 shares of the stock in a transaction that occurred on Monday, May 4th. The stock was purchased at an average cost of $21.18 per share, for a total transaction of $264,750.00. Following the completion of the acquisition, the chief executive officer owned 695,152 shares in the company, valued at $14,723,319.36. This trade represents a 1.83% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Timothy P. Sullivan bought 24,154 shares of the stock in a transaction that occurred on Thursday, May 7th. The stock was bought at an average price of $20.69 per share, with a total value of $499,746.26. Following the completion of the acquisition, the director owned 73,383 shares of the company’s stock, valued at $1,518,294.27. This trade represents a 49.06% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last three months, insiders purchased 73,264 shares of company stock worth $1,548,316. 1.70% of the stock is owned by company insiders.

Institutional Investors Weigh In On Option Care Health

A number of institutional investors have recently bought and sold shares of the stock. Summitry LLC purchased a new stake in Option Care Health in the first quarter valued at approximately $200,000. Bank of America Corp DE grew its holdings in Option Care Health by 14.6% in the first quarter. Bank of America Corp DE now owns 1,945,015 shares of the company’s stock valued at $52,360,000 after purchasing an additional 247,766 shares during the period. Edgestream Partners L.P. purchased a new stake in Option Care Health in the first quarter valued at approximately $423,000. Adalta Capital Management LLC grew its holdings in Option Care Health by 45.6% in the first quarter. Adalta Capital Management LLC now owns 30,405 shares of the company’s stock valued at $819,000 after purchasing an additional 9,525 shares during the period. Finally, Talon Private Wealth LLC purchased a new stake in Option Care Health in the first quarter valued at approximately $590,000. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Stock Performance

Shares of NASDAQ OPCH opened at $20.08 on Tuesday. The company has a market cap of $3.15 billion, a PE ratio of 15.57, a price-to-earnings-growth ratio of 1.14 and a beta of 0.67. Option Care Health has a 12 month low of $18.01 and a 12 month high of $36.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07. The company has a 50-day simple moving average of $24.17 and a 200-day simple moving average of $29.48.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings results on Thursday, April 30th. The company reported $0.40 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.03. The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.39 billion. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The company’s quarterly revenue was up 1.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.40 earnings per share. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. On average, equities analysts anticipate that Option Care Health will post 1.64 earnings per share for the current year.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.